A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
ANDROMEDA is a first-in-human, Phase I/II, open-label, multicenter study of AZD9750 in participants with metastatic prostate cancer. The trial evaluates safety, tolerability, pharmacokinetics/pharmacodynamics, and preliminary efficacy of AZD9750 as monotherapy and in combination with saruparib.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony rak gruczołowy prostaty
- •Rak rozszerzył się na inne części ciała (przerzuty)
- •Bardzo niski poziom testosteronu we krwi
- •Dowód pogorszenia się choroby: wzrost PSA, rozrost guza lub nowe zmiany w kościach
- •Dobry stan ogólny (możliwość codziennych czynności)
- •Prawidłowe funkcjonowanie szpiku kostnego i organów
✗ Disqualifies
- •Inne typy raka prostaty niż zwykły rak gruczołowy
- •Przerzuty do mózgu lub uciśnięcie rdzenia kręgowego
- •Poważne problemy z sercem
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 10, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (18)
Research Site
Duarte, United States
Research Site
San Francisco, United States
Research Site
Tampa, United States
Research Site
Boston, United States
Research Site
St Louis, United States
Research Site
Myrtle Beach, United States
Research Site
Nashville, United States
Research Site
Salt Lake City, United States
Research Site
Melbourne, Australia
Research Site
Calgary, Canada
Research Site
Vancouver, Canada
Research Site
Chengdu, China
Research Site
Chūōku, Japan
Research Site
Kashiwa, Japan
Research Site
Amsterdam, Netherlands
Research Site
Rotterdam, Netherlands
Research Site
Barcelona, Spain
Research Site
Cambridge, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.